Publications by authors named "Javier Garau"

Claim this Profile
D
Determining the optimal antibiotic duration for skin and soft tissue infections.
Javier Garau

Curr Opin Infect Dis· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short versus long course therapy in the treatment of febrile urinary tract infections in men based on serum PSA values.
Helena Monzón, Laura Gisbert, Meritxell Salvadó, Miquel Puyol, Mariona Xercavins, Javier Garau

Eur J Intern Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of pneumococcal pneumonia diagnosis using quantitative real-time PCR targeting lytA in adult patients: a prospective cohort study.
Lucía Boix-Palop, Meritxell Obradors, Mariona Xercavins, Ester Picó-Plana, Lydia Canales, Javier Garau

Clin Microbiol Infect· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections.
Matteo Bassetti, Javier Garau

J Antimicrob Chemother· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Related Factors to Streptococcus pneumoniae Invasive Infection and Clinical Manifestations: The Potential Role of Nasopharyngeal Microbiome.
Beatriz Dietl, Desirée Henares, Lucía Boix-Palop, Carmen Muñoz-Almagro, Javier Garau

Front Med (Lausanne)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and economic impact of bacterial resistance: an approach to infection control and antimicrobial stewardship solutions.
Esther Calbo, Lucía Boix-Palop, Javier Garau

Curr Opin Infect Dis· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed Cerebral Vasculopathy in Pneumococcal Meningitis: Epidemiology and Clinical Outcome. A Cohort Study.
Lucía Boix-Palop, Tamara Fernández, Iván Pelegrín, Meritxell Obradors, Kevin García-Roulston, Javier Garau

Int J Infect Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for Covid-19 in Skilled Nursing Facilities.
Esther Calbo, Úrsula Masats, Javier Garau

N Engl J Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update on the role of ceftazidime-avibactam in the management of carbapenemase-producing Enterobacterales.
Beatriz Dietl, Laura M Martínez, Esther Calbo, Javier Garau

Future Microbiol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibiotic treatment for pneumonia complicating stroke: Recommendations from the pneumonia in stroke consensus (PISCES) group.
Amit K Kishore, Adam R Jeans, Javier Garau, Alejandro Bustamante, Lalit Kalra

Eur Stroke J· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of pharmacists in antimicrobial stewardship programmes.
Javier Garau, Matteo Bassetti

Int J Clin Pharm· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiological Etiologies of Pneumonia Complicating Stroke: A Systematic Review.
Amit K Kishore, Andy Vail, Adam R Jeans, Angel Chamorro, Mario Di Napoli, Javier Garau

Stroke· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methicillin-resistant Staphylococcus aureus.
Andie S Lee, Hermínia de Lencastre, Javier Garau, Jan Kluytmans, Surbhi Malhotra-Kumar

Nat Rev Dis Primers· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic susceptibility to invasive pneumococcal disease.
Anna Sangil, María J Arranz, Roberto Güerri-Fernández, Maite Pérez, Helena Monzón, Javier Garau

Infect Genet Evol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging extended-spectrum β-lactamase-producing Klebsiella pneumoniae causing community-onset urinary tract infections: a case-control-control study.
Lucía Boix-Palop, Mariona Xercavins, Cristina Badía, Meritxell Obradors, Montserrat Riera, Javier Garau

Int J Antimicrob Agents· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive and prognostic factors in patients with blood-culture-positive community-acquired pneumococcal pneumonia.
Rosanel Amaro, Adamantia Liapikou, Catia Cilloniz, Albert Gabarrus, Francesc Marco, Javier Garau

Eur Respir J· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe.
Dilip Nathwani, Matthew Dryden, Javier Garau

Int J Antimicrob Agents· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing epidemiology of hospital outbreaks due to ESBL-producing Klebsiella pneumoniae: the CTX-M-15 type consolidation.
Esther Calbo, Javier Garau

Future Microbiol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.
Noemí Alonso, Elisenda Miró, Vanesa Pascual, Alba Rivera, Maria Simó, Javier Garau

Int J Antimicrob Agents· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of vaccination on invasive pneumococcal disease in adults with focus on the immunosuppressed.
Anna Sangil, Mariona Xercavins, Mònica Rodríguez-Carballeira, Marta Andrés, Montse Riera, Javier Garau

J Infect· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacological approach for balancing the use of daptomycin and linezolid in comparison with that of vancomycin in the treatment of MRSA-related infections.
Federico Pea, Nicola Petrosillo, Javier Garau

Expert Rev Anti Infect Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis of Stroke-Associated Pneumonia: Recommendations From the Pneumonia in Stroke Consensus Group.
Craig J Smith, Amit K Kishore, Andy Vail, Angel Chamorro, Javier Garau

Stroke· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How is pneumonia diagnosed in clinical stroke research? A systematic review and meta-analysis.
Amit K Kishore, Andy Vail, Angel Chamorro, Javier Garau, Stephen J Hopkins

Stroke· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology and risk factors for infections due to AmpC β-lactamase-producing Escherichia coli.
Vanesa Pascual, Gabriel Ortiz, Maria Simó, Noemí Alonso, Maria Consol Garcia, Javier Garau

J Antimicrob Chemother· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.
Javier Garau, Francesco Blasi, Jesús Medina, Kyle McBride, Helmut Ostermann

BMC Infect Dis· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis